Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Imunon, Inc. (IMNN)

Imunon posts investor presentation for October 2026 investor calls and conferences

Neutral Impact 1 of 5 other Written later

Imunon, Inc. made an investor presentation available on October 26, 2026, which it expects to use in investor calls and conferences. The filing attaches the presentation as Exhibit 99.1 and contains no new financial results, guidance, or transaction terms.

Key points

  • Investor presentation made available October 26, 2026, titled "Imunon, Inc. Investor Presentation October 2026"
  • Company expects to use the presentation in investor calls and/or conferences
  • Filing includes no financial figures, guidance, or deal terms in the 8-K text

The filing

CompanyImunon, Inc. (IMNN)
Form8-K, current report
Filed with the SECOct 27, 2026, 6:05 AM ET
Accession number0001493152-26-048625

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.